Annals of Hematology

, Volume 87, Issue 7, pp 591–592 | Cite as

Sickle cell disease, pulmonary hypertension, and sarcoidosis

Letter to the Editor

References

  1. 1.
    Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, Brown B, Coles WA, Nichols JS, Ernst I, Hunter LA, Blackwelder WC, Schechter AN, Rodgers GP, Castro O, Ognibene FP (2004) Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 350(9):886–895PubMedCrossRefGoogle Scholar
  2. 2.
    Lee MT, Rosenzweig EB, Cairo MS (2007) Pulmonary hypertension in sickle cell disease. Clin Adv Hematol Oncol 5(8):645–653PubMedGoogle Scholar
  3. 3.
    Couillard S, Benkerrou M, Girot R, Brousse V, Ferster A, Bader-Meunier B (2007) Steroid treatment in children with sickle-cell disease. Haematologica 92(3):425–426PubMedCrossRefGoogle Scholar
  4. 4.
    Guvenc B, Unsal C, Hanta I, Unsal A, Guvenc H (2005) Sickle cell anemia patient with sarcoidosis-associated inguinal lymph node and lung infiltration. J Natl Med Assoc 97(6):820–822PubMedGoogle Scholar
  5. 5.
    Hall G, Carter J (1993) Sarcoidosis and sickle cell disease. Ann Intern Med 118(2):157–158PubMedGoogle Scholar
  6. 6.
    Zwerdling T, Kalinyak K, Rucknagel D (1994) Sarcoidosis in a child with sickle cell anemia. Am J Pediatr Hematol Oncol 16(3):278–282PubMedCrossRefGoogle Scholar
  7. 7.
    Greenberg SR, Atwater J, Israel HL (1965) Frequency Of Hemoglobinopathies In Sarcoidosis. Ann Intern Med 62:125–128PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  1. 1.Department of CardiologyCharité Universitätsmedizin Berlin, Campus Virchow KlinikumBerlinGermany
  2. 2.Department of Hematology and OncologyCharité Universitätsmedizin Berlin, Campus Virchow KlinikumBerlinGermany

Personalised recommendations